CTOs on the Move

Saoi Technology

www.saoi-tech.com

 
Saoi Technology serves Private Equity Firms, Venture Capital Firms, and Sophisticated Investors that want high impact results. We take a collaborative approach to problem solving and produce innovative solutions. Since Saoi Technology`s inception in early 2016, it has already made large impact across a variety of ventures including pharmacy software industry roll up, clinical services start up, security analytics firm ramp up, and a technology firm public to private transaction. We have offered services such as operating executives, M&A due diligence, product strategy, and technical advisory on complex deals and investment thesis. Let us help you to meet your business ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

DigiLens

DigiLens is a Sunnyvale, CA-based company in the Computers and Electronics sector.

Zatso

Zatso is a San Francisco, CA-based company in the Computers and Electronics sector.

EMM

EMM is a Norcross, GA-based company in the Computers and Electronics sector.

INDUS Corporation

INDUS Corporation is a privately held provider of IT services meeting mission-critical requirements of United States Government Civilian, Defense, Homeland Security, and Intelligence organizations. INDUS' services include Secure IT Infrastructure, Actionable Intelligence, Software Applications Management, and Enterprise IT.

IdentifySensors

IdentifySensors is a leading developer of digital diagnostic technologies on graphene-based biosensors. The company is principally focused on developing real-time pathogen detection capabilities for direct diagnosis and remote monitoring. The company`s technology has expanded into multiple industries and applications, such as pathogen diagnostics and testing for food contamination. Check4® by IdentifySensors Biologics® is a next-generation digital diagnostic platform intended to detect multiple pathogens within 5 minutes at the molecular gene level. The platform is intended to eliminates the need for enzymatic amplification and reagents. Graphene sensor technology has moved diagnostics beyond chemical testing into a rapid digital platform intended to be as accurate as a PCR test but significantly more sensitive and cost effective. Printed graphene sensors isolate targeted viruses and bacteria from saliva and other bodily fluids within a handheld, Bluetooth device. The platform is intended to detect the genetic material of dozens of pathogens for over-the-counter and point-of-care use. With a target price at a fraction of current molecular tests, Check4® is intended to disrupt the PCR market for many infections. The Check4® testing platform comes is two main parts: 1) A reader, which connects to a user`s cell phone or to a clinical database; and 2) Single-use test cartridges, which can contain multiple graphene sensors to detect multiple infections. The reader, which can be reused thousands of times, serves as the base of the platform, accepting any number of test cartridges. Disposable test cartridges, which require the reader to work, will be sold separately.